NCT00225017 Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study Status COMPLETED Phase PHASE3
NCT00224822 The Effects of Aripiprazole on Patients With Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT00223496 12- Week Open Label Treatment of Refractory Bipolar Depression Status COMPLETED Phase PHASE4
NCT00223418 Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills Status COMPLETED Phase NA
NCT00222833 The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00221962 Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder) Status COMPLETED Phase PHASE4
NCT00221416 An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00220636 Abilify as an Adjunctive Treatment for Refractory Depression Status COMPLETED Phase PHASE4
NCT00216203 Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00213746 Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study) Status COMPLETED Phase N/A
NCT00211302 Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) Status TERMINATED Phase NA
NCT00210249 Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment Status COMPLETED Phase N/A
NCT00209027 The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia Status TERMINATED Phase NA
NCT00207168 To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine Status COMPLETED Phase PHASE4
NCT00207142 Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) Status COMPLETED Phase PHASE4
NCT00207103 MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1